The clinical significance of drug–drug interactions in the era of direct‐acting anti‐viral agents against chronic hepatitis C

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|38|11-12|1365-1372

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.38, Iss.11-12, 2013-12, pp. : 1365-1372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The efficacy and safety of direct acting antiviral treatment and clinical significance of drug–drug interactions in elderly patients with chronic hepatitis C virus infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 856-865

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct‐acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1298-1303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct‐acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs

By  

HEPATOLOGY, Vol. 62, Iss. 4, 2015-10 ,pp. : 1298-1303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Will IL28B polymorphism remain relevant in the era of direct‐acting antiviral agents for hepatitis C virus?

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 373-381

John Wiley & Sons Inc

Access to resources Recommend Favorite

Difficult‐to‐cure populations with chronic hepatitis c: Vanishing in the direct‐acting antiviral era?

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 4-7

John Wiley & Sons Inc

Access to resources Recommend Favorite